Navigation Links
UBM Medica's ONCOLOGY to Feature Special Content on Role of Genetic Testing in GI Cancers
Date:2/10/2012

NORWALK, Conn., Feb. 10, 2012 /PRNewswire/ -- UBM Medica's ONCOLOGY and CancerNetwork today announced that the April issue will feature insights by physicians from the clinical genetics service at Memorial Sloan-Kettering Cancer Center in which they explain the role of genetic testing in gastrointestinal cancers.

In the article, Kenneth Offit, MD, MPH, and colleagues bring clarity to when, why—and to what end—to refer patients for genetic testing for GI cancers. Using a case-based approach to illustrate what is known and unknown about weak and strong hereditary factors for GI cancers, the authors demonstrate how this knowledge can be used to improve outcomes in those who are predisposed to developing these malignancies.

"While there has been extraordinary attention paid by oncologists ... to inherited breast and ovarian cancer, the syndromes of predisposition to colon, gastric, and other GI cancers are of equal importance," said Dr. Offit, who is currently Chief of the Clinical Genetics Service at Memorial Sloan-Kettering. He noted that although "the genetics of hereditary colon cancer, for example, appears much more complex than breast cancer, as it involves several genes and dominant as well as recessive forms of inheritance," genetic counseling and testing for colon cancer risk has an important advantage: the availability of targeted endoscopic surveillance to remove premalignant lesions. The authors point out that "there are relatively few diseases in which early identification of at-risk individuals can have such dramatic outcomes from primary disease prevention."

The authors include Kasmintan Schrader, MD, Kenneth Offit, MD, MPH, and Zsofia K. Stadler, MD. Dr. Offit is known world-wide for his work in cancer genetics. It was his research group that in 1996 first described the common genetic mutations of the BRCA1 and BRCA2 genes that are associated with increased breast cancer risk.

About UBM Medica

Addressing today's healthcare information needs, UBM Medica, a division of UBM plc (UBM.L), delivers strategic, integrated communications solutions and comprehensive reach—online, in print, live, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, drug databases, data services, live events, and other valuable resources, UBM Medica also delivers comprehensive communication solutions for the pharmaceutical and related industries. US websites include PsychiatricTimes.com, CancerNetwork.com, DiagnosticImaging.com, ConsultantLive.com, OBGYN.net, PhysiciansPractice.com and SearchMedica.com.  Employing more than 1,400 people with offices in 29 countries, UBM Medica is headquartered in London.  For more information, visit http://www.ubmmedica.com/.

Media contact:
Amy Erdman
Director of Marketing
203-523-7041
amy.erdman@ubm.com


'/>"/>
SOURCE UBM Medica
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):